Drug-drug interaction between danshensu and irbesartan and its potential mechanism

References

• Abraham S, Nohria A, Neilan TG, Asnani A, Saji AM, Shah J, Lech T, Grossman J, Abraham GM, McQuillen DP, et al. 2022. Cardiovascular drug interactions with nirmatrelvir/ritonavir in patients with COVID-19: JACC review topic of the week. J Am Coll Cardiol. 80(20):1912–1924. doi: 10.1016/j.jacc.2022.08.800.
   PubMed Web of Science ®Google Scholar
• Bourrié M, Meunier V, Berger Y, Fabre G. 1999. Role of cytochrome P-4502C9 in irbesartan oxidation by human liver microsomes. Drug Metab Dispos. 27(2):288–296.
   PubMed Web of Science ®Google Scholar
• Cho CK, Kang P, Jang CG, Lee SY, Lee YJ, Choi CI. 2023. Physiologically based pharmacokinetic (PBPK) modeling to predict the pharmacokinetics of irbesartan in different CYP2C9 genotypes. Arch Pharm Res. 46(11–12):939–953. doi: 10.1007/s12272-023-01472-z.
   PubMed Web of Science ®Google Scholar
• Choi CI, Kim MJ, Chung EK, Lee HI, Jang CG, Bae JW, Lee SY. 2012. CYP2C9 3 and 13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects. Eur J Clin Pharmacol. 68(2):149–154. doi: 10.1007/s00228-011-1098-0.
   PubMed Web of Science ®Google Scholar
• Darwish IA, Darwish HW, Bakheit AH, Al-Kahtani HM, Alanazi Z. 2021. Irbesartan (a comprehensive profile). Profiles Drug Subst Excip Relat Methodol. 46:185–272. doi: 10.1016/bs.podrm.2020.07.004.
   PubMedGoogle Scholar
• Elgawish MS, Soltan MK, Sebaiy MM. 2019. An LC-MS/MS spectrometry method for the simultaneous determination of Rosuvastatin and Irbesartan in rat plasma: insight into pharmacokinetic and drug-drug interaction studies. J Pharm Biomed Anal. 174:226–234. doi: 10.1016/j.jpba.2019.05.069.
   PubMed Web of Science ®Google Scholar
• Feng L, Fu S, Du W, Wang B, Li L, Zhu M, Liu C, Zhang J. 2015. Validation and application of an rapid HPLC-MS method for the determination of salvianic acid A in human plasma. J Chromatogr Sci. 53(5):771–777. doi: 10.1093/chromsci/bmu124.
   PubMed Web of Science ®Google Scholar
• Han CD, Wang CC, Huang L, Chen X. 2023. MCFF-MTDDI: multi-channel feature fusion for multi-typed drug-drug interaction prediction. Brief Bioinform. 24(4):bbad215. doi: 10.1093/bib/bbad215.
   Web of Science ®Google Scholar
• Hu YN, Zhou BT, Yang HR, Peng QL, Gu XR, Sun SS. 2021. Effect of rifampicin on anticoagulation of warfarin: a case report. World J Clin Cases. 9(5):1087–1095. doi: 10.12998/wjcc.v9.i5.1087.
   PubMed Web of Science ®Google Scholar
• Le J, Liao Y, Li S, Chen X, Hong Z. 2021. High-throughput LC-MS/MS method for simultaneous determination of pantoprazole and atorvastatin in rat plasma: application to a pharmacokinetic interaction study. Curr Drug Metab. 22(6):481–490. doi: 10.2174/1389200222666210520090632.
   PubMed Web of Science ®Google Scholar
• Li H, Song F, Duan LR, Sheng JJ, Xie YH, Yang Q, Chen Y, Dong QQ, Zhang BL, Wang SW. 2016. Paeonol and danshensu combination ­attenuates apoptosis in myocardial infarcted rats by inhibiting ­oxidative stress: roles of Nrf2/HO-1 and PI3K/Akt pathway. Sci Rep. 6(1):23693. doi: 10.1038/srep23693.
   PubMed Web of Science ®Google Scholar
• Li H, Xie YH, Yang Q, Wang SW, Zhang BL, Wang JB, Cao W, Bi LL, Sun JY, Miao S, et al. 2012. Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. PLoS One. 7(11):e48872. doi: 10.1371/journal.pone.0048872.
   PubMed Web of Science ®Google Scholar
• Liu A, Shen Y, Du Y, Chen J, Pei F, Fu W, Qiao J. 2018. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice. Microb Pathog. 125:418–422. doi: 10.1016/j.micpath.2018.10.003.
   PubMed Web of Science ®Google Scholar
• Madrid AH, Bueno MG, Rebollo JMG, Marín I, Peña G, Bernal E, Rodriguez A, Cano L, Cano JM, Cabeza P, et al. 2002. Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation: a prospective and randomized study. Circulation. 106(3):331–336. doi: 10.1161/01.cir.0000022665.18619.83.
   PubMed Web of Science ®Google Scholar
• Qiu F, Zhang R, Sun J, Jiye A, Hao H, Peng Y, Ai H, Wang G. 2008. Inhibitory effects of seven components of danshen extract on catalytic activity of cytochrome P450 enzyme in human liver microsomes. Drug Metab Dispos. 36(7):1308–1314. doi: 10.1124/dmd.108.021030.
   PubMed Web of Science ®Google Scholar
• Secora A, Alexander GC, Ballew SH, Coresh J, Grams ME. 2018. Kidney function, polypharmacy, and potentially inappropriate medication use in a community-based cohort of older adults. Drugs Aging. 35(8):735–750. doi: 10.1007/s40266-018-0563-1.
   PubMed Web of Science ®Google Scholar
• Shahid M, Ahmad A, Raish M, Bin Jardan YA, Alkharfy KM, Ahad A, Abul Kalam M, Ahmad Ansari M, Iqbal M, Ali N, et al. 2023. Herb-drug interaction: effect of sinapic acid on the pharmacokinetics of dasatinib in rats. Saudi Pharm J. 31(11):101819. doi: 10.1016/j.jsps.2023.101819.
   PubMed Web of Science ®Google Scholar
• Spinar J, Vítovec J. 2012. [AII antagonists (candesartan and irbesartan) in the treatment of cardiovascular diseases]. Vnitr Lek. 58(10):755–760.
   PubMedGoogle Scholar
• Sun DW, Gao Q, Qi X. 2020. Danshensu ameliorates cardiac ischaemia reperfusion injury through activating Sirt1/FoxO1/Rab7 signal pathway. Chin J Integr Med. 26(4):283–291. doi: 10.1007/s11655-019-3165-9.
   PubMed Web of Science ®Google Scholar
• Tang Y, Wang M, Chen C, Le X, Sun S, Yin Y. 2011. Cardiovascular protection with danshensu in spontaneously hypertensive rats. Biol Pharm Bull. 34(10):1596–1601. doi: 10.1248/bpb.34.1596.
   PubMed Web of Science ®Google Scholar
• Wang D, Fan G, Wang Y, Liu H, Wang B, Dong J, Zhang P, Zhang B, Karas RH, Gao X, et al. 2013. Vascular reactivity screen of Chinese medicine danhong injection identifies Danshensu as a NO-independent but PGI2-mediated relaxation factor. J Cardiovasc Pharmacol. 62(5):457–465. doi: 10.1097/FJC.0b013e3182a29657.
   PubMed Web of Science ®Google Scholar
• Wang Q, Li J, Chu X, Jiang X, Zhang C, Liu F, Zhang X, Li Y, Shen Q, Pang B. 2023. Potential chemoprotective effects of active ingredients in Salvia miltiorrhiza on doxorubicin-induced cardiotoxicity: a systematic review of in vitro and in vivo studies. Front Cardiovasc Med. 10:1267525. doi: 10.3389/fcvm.2023.1267525.
   PubMed Web of Science ®Google Scholar
• Wang T, Li C, Han B, Wang Z, Meng X, Zhang L, He J, Fu F. 2020. Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo. BMC Complement Med Ther. 20(1):20. doi: 10.1186/s12906-019-2738-7.
   PubMedGoogle Scholar
• Wang Y, Rui R, Zhang X, Sun B. 2021. Pharmacokinetic study on the ­interaction between succinic acid and irbesartan in rats and its ­potential mechanism. Pharm Biol. 59:1619–1622.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang J, Fu W, Zhou P, He Y, Fang M, Wan H, Zhou H. 2022. Pharmacokinetic Comparison of Nine Bioactive Compounds of Guanxinshutong Capsule in Normal and Acute Myocardial Infarction Rats. Eur J Drug Metab Pharmacokinet. 47(5):653–665. doi: 10.1007/s13318-022-00777-6.
   PubMed Web of Science ®Google Scholar
• Ye L, Fan S, Zhao P, Wu C, Liu M, Hu S, Wang P, Wang H, Bi H. 2023. Potential herb–drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. Acta Pharm Sin B. 13(9):3598–3637. doi: 10.1016/j.apsb.2023.06.001.
   PubMed Web of Science ®Google Scholar
• Ye LH, Zhao XQ, Kong LT, Wang LS, Tao X, Wu H, He M, Chang Q. 2018. Inhibitory effects of Danhong Injection and its major constituents on human cytochrome P450 enzymes in vitro. Biomed Chromatogr. 32(8):e4250. doi: 10.1002/bmc.4250.
   PubMed Web of Science ®Google Scholar
• Ye T, Xiong D, Chen L, Li Y, Gong S, Zhang L, Li B, Pan J, Qian J, Qu H. 2020. Effect of Danshen on TLR2-triggered inflammation in macrophages. Phytomedicine. 70:153228. doi: 10.1016/j.phymed.2020.153228.
   PubMed Web of Science ®Google Scholar
• Yoo YG, Lim MJ, Kim JS, Jeong HE, Ko H, Shin JY. 2023. Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients. Medicine (Baltimore). 102(46):e36098. doi: 10.1097/MD.0000000000036098.
   PubMed Web of Science ®Google Scholar
• Yu C, Qi D, Lian W, Li QZ, Li HJ, Fan HY. 2014. Effects of danshensu on platelet aggregation and thrombosis: in vivo arteriovenous shunt and venous thrombosis models in rats. PLoS One. 9(11):e110124. doi: 10.1371/journal.pone.0110124.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zhang Q, Liu G, Zhang N. 2019. Therapeutic potentials and mechanisms of the Chinese traditional medicine Danshensu. Eur J Pharmacol. 864:172710. doi: 10.1016/j.ejphar.2019.172710.
   PubMed Web of Science ®Google Scholar
• Zhou H, Li W, Sun L, Li W, Liu Q. 2021. A rapid LC-MS/MS method for simultaneous determination of berberine and irbesartan in rat plasma: application to the drug-drug pharmacokinetic interaction study after oral administration in rats. Biomed Chromatogr. 35:e5144.
   PubMed Web of Science ®Google Scholar
• Zhou P, An B, Zhang X, Lv J, Lin B. 2022. Therapeutic effect and mechanism of danshensu on coronary heart disease using liquid chromatography combined with mass spectrometry metabolomics. J Chromatogr B Analyt Technol Biomed Life Sci. 1208:123400. doi: 10.1016/j.jchromb.2022.123400.
   PubMed Web of Science ®Google Scholar
• Zhou X, Chan SW, Tseng HL, Deng Y, Hoi PM, Choi PS, Or PM, Yang JM, Lam FF, Lee SM, et al. 2012. Danshensu is the major marker for the antioxidant and vasorelaxation effects of Danshen (Salvia miltiorrhiza) water-extracts produced by different heat water-extractions. Phytomedicine. 19(14):1263–1269. doi: 10.1016/j.phymed.2012.08.011.
   PubMed Web of Science ®Google Scholar